Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunil Healthcare Ltd reported audited results for FY2026. Standalone performance deteriorated significantly with a loss of Rs. 707.81 Lakhs compared to a profit of Rs. 616.31 Lakhs in FY2025—a sharp reversal. The company recorded substantial exceptional items: Rs. 946.66 Lakhs (related to insurance claim provision) and Rs. 344.35 Lakhs (insurance claim receivable). Consolidated results showed a loss of Rs. 804.58 Lakhs (vs profit of Rs. 645.11 Lakhs in FY2025). The nine-month figures (Q3 YTD Dec 2025) showed standalone profit of Rs. 250.34 Lakhs but consolidated profit of Rs. 545.11 Lakhs, suggesting the loss was primarily in Q4. The Board did not recommend any dividend for FY 2025-26. Two foreign subsidiaries reported significant losses totaling approximately Rs. 259 Lakhs for the year. Auditors issued unmodified (clean) opinions on both standalone and consolidated financial statements.
The company swung from profit to loss in FY2026 due to exceptional items and likely operational challenges. The absence of dividend and significant losses may negatively impact investor sentiment. The large exceptional items related to insurance claims indicate one-time charges that could normalize future results.